AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29113731 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fexinidazole
Number of subjects: 394
Study 29113731 — intervention group
Group type: COMPARATOR
Intervention: Nifurtimox eflornithine combination therapy
Number of subjects: 394
Study 26987694 — intervention group
Group type: EXPERIMENTAL
Intervention: Single miniplate fixation with MMF (n=37)
Number of subjects: 134
Study 26987694 — intervention group
Group type: EXPERIMENTAL
Intervention: Double miniplate fixation with MMF (n=59)
Number of subjects: 134
Study 26987694 — intervention group
Group type: EXPERIMENTAL
Intervention: Double miniplate fixation without MMF (n=38)
Number of subjects: 134
Study 24674974 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored counseling
Number of subjects: 48
Study 24674974 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 23085245 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (40 mg daily)
Number of subjects: 110
Study 23085245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 20220537 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Group (EG)
Number of subjects: 128
Study 20220537 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and Cimicifuga racemosa Group (EGCR)
Number of subjects: 128
Study 20220537 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 128
Study 18977983 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with desmopressin and extended-release anticholinergic medication
Number of subjects: 41
Study 18977983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 15848990 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacilli-prepared tampons
Number of subjects: 0
Study 15848990 — intervention group
Group type: COMPARATOR
Intervention: Placebo tampons
Number of subjects: 0
Study 15848990 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate wet smear ratings according to Nugent's classification
Number of subjects: 0
Study 12747444 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) chip
Number of subjects: 44
Study 12747444 — intervention group
Group type: COMPARATOR
Intervention: Sham chip placement
Number of subjects: 44
Study 10902822 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral vasodilatation measured by the ratio I/A of the maternal sphygmogram
Number of subjects: 11
Study 10902822 — intervention group
Group type: EXPERIMENTAL
Intervention: Glomerular filtration rate (GFR) measured with the in vitro radiofluorescent method
Number of subjects: 11
Study 10902822 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac output determined by the ejection angle from maternal carotid sphygmogram
Number of subjects: 11
Study 10902822 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracellular volume measurement
Number of subjects: 11
Study 8632337 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol administration (10 mg twice daily) with NH4Cl (1.5 g every 6 hr)
Number of subjects: 8
Study 8632337 — intervention group
Group type: COMPARATOR
Intervention: Control phase: Pindolol administration (10 mg twice daily) without NH4Cl
Number of subjects: 8
Study 1313864 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula plus gamma-linolenic acid
Number of subjects: 0
Study 1313864 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula plus cholesterol
Number of subjects: 0
Study 1313864 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 0
Study 1313864 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 0
Study 2931247 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/NG (ethinyl estradiol and levonorgestrel)
Number of subjects: 11
Study 2931247 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/DG (ethinyl estradiol and desogestrel)
Number of subjects: 11
Study 2931247 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/NG
Number of subjects: 11
Study 2931247 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/DG
Number of subjects: 11
Study 2931247 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EE/NG and EE/DG
Number of subjects: 11
Study 31856001 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and progressive mobility program with five levels of activity
Number of subjects: 99
Study 31856001 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment without a preestablished routine
Number of subjects: 99
Study 31856001 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and progressive mobility program
Number of subjects: 99
Study 30213095 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium citrate (30 mEq day‐1)
Number of subjects: 40
Study 30213095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 27237964 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Optix Aqua multifocal
Number of subjects: 35
Study 27237964 — intervention group
Group type: EXPERIMENTAL
Intervention: PureVision 2 for Presbyopia
Number of subjects: 35
Study 27237964 — intervention group
Group type: EXPERIMENTAL
Intervention: Acuvue OASYS for Presbyopia
Number of subjects: 35
Study 27237964 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofinity multifocal
Number of subjects: 35
Study 27237964 — intervention group
Group type: EXPERIMENTAL
Intervention: Monovision
Number of subjects: 35
Study 24585474 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic models
Number of subjects: 0
Study 24585474 — intervention group
Group type: EXPERIMENTAL
Intervention: Organ dissections
Number of subjects: 0
Study 24585474 — intervention group
Group type: COMPARATOR
Intervention: Virtual dissections
Number of subjects: 0
Study 22461037 — intervention group
Group type: EXPERIMENTAL
Intervention: Live donor champion (LDC) intervention
Number of subjects: 30
Study 22461037 — intervention group
Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 30
Study 20576482 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (5 sessions of 45 min per week at 65-70% max HR for 4 menstrual cycles)
Number of subjects: 391
Study 20576482 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 391
Study 17137759 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 7728
Study 17137759 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 7728
Study 17137759 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 7728
Study 17137759 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 7728
Study 17137759 — intervention group
Group type: COMPARATOR
Intervention: Amisulpride
Number of subjects: 7728
Study 17137759 — intervention group
Group type: COMPARATOR
Intervention: Typical antipsychotics (oral and depot)
Number of subjects: 7728
Study 15818610 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid (VIA)
Number of subjects: 142701
Study 15818610 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytology
Number of subjects: 142701
Study 15818610 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 142701
Study 15818610 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 142701
Study 11939808 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2a, 6 x 10(6) IU, subcutaneously 3 times per week for 3 months
Number of subjects: 50
Study 11939808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 10219009 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity cycling (70% heart rate reserve)
Number of subjects: 39
Study 10219009 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity cycling (40% heart rate reserve)
Number of subjects: 39
Study 10219009 — intervention group
Group type: COMPARATOR
Intervention: Both high-intensity and low-intensity cycling
Number of subjects: 39
Study 10155353 — intervention group
Group type: EXPERIMENTAL
Intervention: Autohaler (AH) early canister life
Number of subjects: 12
Study 10155353 — intervention group
Group type: EXPERIMENTAL
Intervention: Autohaler (AH) late canister life
Number of subjects: 12
Study 10155353 — intervention group
Group type: EXPERIMENTAL
Intervention: Autohaler (AH)
Number of subjects: 12
Study 2368243 — intervention group
Group type: EXPERIMENTAL
Intervention: He‐Ne laser therapy
Number of subjects: 48
Study 2368243 — intervention group
Group type: COMPARATOR
Intervention: Placebo (slit lamp with blinking light)
Number of subjects: 48
Study 2368243 — intervention group
Group type: COMPARATOR
Intervention: No treatment (absolute controls)
Number of subjects: 48
Study 519269 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and tailoring programme for compliance improvement
Number of subjects: 82
Study 519269 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with medication monitor
Number of subjects: 82
Study 31418925 — intervention group
Group type: EXPERIMENTAL
Intervention: Biophilic design in VR
Number of subjects: 30
Study 31418925 — intervention group
Group type: COMPARATOR
Intervention: Base case (no biophilic elements)
Number of subjects: 30
Study 29173199 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (3.7 g daily)
Number of subjects: 98
Study 29173199 — intervention group
Group type: COMPARATOR
Intervention: Control (olive oil)
Number of subjects: 98
Study 26209000 — intervention group
Group type: EXPERIMENTAL
Intervention: LCZ696 (dual‐acting angiotensin receptor blocker and neprilysin inhibitor)
Number of subjects: 0
Study 26209000 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (ACE inhibitor)
Number of subjects: 0
Study 26209000 — intervention group
Group type: EXPERIMENTAL
Intervention: LCZ696
Number of subjects: 0
Study 24635770 — intervention group
Group type: EXPERIMENTAL
Intervention: High-target group (80 to 85 mm Hg)
Number of subjects: 776
Study 24635770 — intervention group
Group type: COMPARATOR
Intervention: Low-target group (65 to 70 mm Hg)
Number of subjects: 776
Study 24635770 — intervention group
Group type: EXPERIMENTAL
Intervention: High-target group (80 to 85 mm Hg) among patients with chronic hypertension
Number of subjects: 776
Study 22562179 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD)
Number of subjects: 61
Study 22562179 — intervention group
Group type: COMPARATOR
Intervention: Low-Fat Diet (LFD)
Number of subjects: 61
Study 19286153 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof Toric IOL implantation
Number of subjects: 32
Study 17880335 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecnic Carbostent (T)
Number of subjects: 63
Study 17880335 — intervention group
Group type: COMPARATOR
Intervention: Rx Multi-Link Penta (P)
Number of subjects: 63
Study 15574547 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg
Number of subjects: 56
Study 15574547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 12074617 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid (Depo‐Medrone) injection preoperatively
Number of subjects: 0
Study 12074617 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultured Dupuytren's cells
Number of subjects: 0
Study 12074617 — intervention group
Group type: COMPARATOR
Intervention: Control fibroblasts from palmar fascia and fascia lata
Number of subjects: 0
Study 9591619 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated combat flight
Number of subjects: 10
Study 9591619 — intervention group
Group type: COMPARATOR
Intervention: Control period (ground duties)
Number of subjects: 10
Study 8175411 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for left sided breast cancer (either tangential field 60Co or electron-therapy)
Number of subjects: 37
Study 8175411 — intervention group
Group type: COMPARATOR
Intervention: Control group (either treated for right sided disease or nonirradiated)
Number of subjects: 37
Study 2681103 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed beam radiation therapy
Number of subjects: 327
Study 2681103 — intervention group
Group type: COMPARATOR
Intervention: Photon radiation therapy
Number of subjects: 327
Study 6988336 — intervention group
Group type: EXPERIMENTAL
Intervention: Valgus osteotomy using a neck‐shaft angle of at least 140 degrees
Number of subjects: 62
Study 6988336 — intervention group
Group type: COMPARATOR
Intervention: Nail plating with 130 degrees neck‐shaft angle
Number of subjects: 62
Study 30482511 — intervention group
Group type: EXPERIMENTAL
Intervention: First trimester tear osmolarity measurement (304.9 ± 8.0 mOsm/L)
Number of subjects: 60
Study 30482511 — intervention group
Group type: EXPERIMENTAL
Intervention: Last trimester tear osmolarity measurement (300.2 ± 7.1 mOsm/L)
Number of subjects: 60
Study 30482511 — intervention group
Group type: EXPERIMENTAL
Intervention: First trimester Schirmer test results (18.1 ± 6.3 mm)
Number of subjects: 60
Study 28112433 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care (medication management)
Number of subjects: 132
Study 28112433 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care (psychotherapy)
Number of subjects: 132
Study 28112433 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care (evidence-based psychotherapy)
Number of subjects: 132
Study 28112433 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care (group psychotherapy)
Number of subjects: 132
Study 28112433 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care (interactive video psychotherapy)
Number of subjects: 132
Study 25847775 — intervention group
Group type: EXPERIMENTAL
Intervention: Huanshuai Recipe Oral Liquid (HSR), 20 mL, 3 times a day for 6 months
Number of subjects: 52
Study 25847775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 23666972 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion (BPD)
Number of subjects: 15
Study 23666972 — intervention group
Group type: EXPERIMENTAL
Intervention: BPD
Number of subjects: 15
Study 21392111 — intervention group
Group type: EXPERIMENTAL
Intervention: Talaporfin sodium (0.25-1.0 mg/kg)
Number of subjects: 20
Study 19413507 — intervention group
Group type: EXPERIMENTAL
Intervention: Four‐Agents‐Decoction (Si Wu Tang)
Number of subjects: 76
Study 19413507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 18490847 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-germinated brown rice (PGBR) diet (3 packs of cooked PGBR, 180 g/pack daily for 6 weeks)
Number of subjects: 11
Study 18490847 — intervention group
Group type: COMPARATOR
Intervention: White rice (WR) diet (3 packs of cooked WR, 180 g/pack daily for 6 weeks)
Number of subjects: 11
Study 15350711 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% ethanol with 0.5% chlorhexidine (CHD group)
Number of subjects: 100
Study 15350711 — intervention group
Group type: COMPARATOR
Intervention: 80% ethanol alone (EtOH group)
Number of subjects: 100
Study 15350711 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CHD and EtOH)
Number of subjects: 100
Study 11506111 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg morphine infiltrated into the harvest site
Number of subjects: 60
Study 11506111 — intervention group
Group type: COMPARATOR
Intervention: 5 mg intramuscular morphine
Number of subjects: 60
Study 11506111 — intervention group
Group type: COMPARATOR
Intervention: Saline infiltrated into the harvest site
Number of subjects: 60
Study 9427017 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy combined with resection surgery
Number of subjects: 150
Study 9427017 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 150
Study 9427017 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (including IORT) with resection surgery
Number of subjects: 150
Study 8321112 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (CARN) 3 g.d-1 for 7 d
Number of subjects: 9
Study 8321112 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CONT)
Number of subjects: 9
Study 8321112 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (CARN)
Number of subjects: 9
Study 3790647 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg Pindolol
Number of subjects: 48
Study 3790647 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg Cloxazolam
Number of subjects: 48
Study 3790647 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg Pindolol + 1.5 mg Cloxazolam
Number of subjects: 48
Study 3790647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 11573527 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 4 mg i.m.
Number of subjects: 108
Study 11573527 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine 2 mg i.m.
Number of subjects: 108
Study 11573527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 45 mg i.m.
Number of subjects: 108
Study 11573527 — intervention group
Group type: COMPARATOR
Intervention: Control (saline i.m.)
Number of subjects: 108
Study 29605459 — intervention group
Group type: EXPERIMENTAL
Intervention: ilioinguinal-iliohypogastric nerve block
Number of subjects: 50
Study 29605459 — intervention group
Group type: COMPARATOR
Intervention: medial transverse abdominis plane block
Number of subjects: 50
Study 29298938 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial photos taken 2 h after injection with 2.0 ng kg‐1 lipopolysaccharide (bacterial stimulus)
Number of subjects: 0
Study 29298938 — intervention group
Group type: COMPARATOR
Intervention: Facial photos taken 2 h after injection with placebo
Number of subjects: 0
Study 29298938 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial cues observed in acutely sick individuals
Number of subjects: 0
Study 27354761 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate intranasal steroid
Number of subjects: 100
Study 27354761 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone furoate intranasal steroid
Number of subjects: 100
Study 25387037 — intervention group
Group type: EXPERIMENTAL
Intervention: Construction task performance methodology
Number of subjects: 96
Study 25387037 — intervention group
Group type: EXPERIMENTAL
Intervention: Construction play performance
Number of subjects: 96
Study 21952693 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein supplementation (40g/day for 8 weeks)
Number of subjects: 352
Study 21952693 — intervention group
Group type: COMPARATOR
Intervention: Milk protein supplementation (40g/day for 8 weeks)
Number of subjects: 352
Study 19785605 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical miltefosine and clobetasol
Number of subjects: 39
Study 19785605 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol
Number of subjects: 39
Study 19785605 — intervention group
Group type: COMPARATOR
Intervention: Topical miltefosine
Number of subjects: 39
Study 17431777 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir 10 mg/day (Group 1)
Number of subjects: 54
Study 17431777 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir 10 mg/day and lamivudine 100 mg once daily (Group 2)
Number of subjects: 54
Study 17431777 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir alone
Number of subjects: 54
Study 16280250 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (1,000-4,000 mg/day)
Number of subjects: 280
Study 16280250 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam monotherapy
Number of subjects: 280
Study 16280250 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 280
Study 12358344 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin nebuliser solution (TNS)
Number of subjects: 115
Study 12358344 — intervention group
Group type: COMPARATOR
Intervention: Colistin
Number of subjects: 115
Study 9949318 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 500 microg twice daily
Number of subjects: 111
Study 9949318 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 1000 microg twice daily
Number of subjects: 111
Study 9949318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 9949318 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 111
Study 7776474 — intervention group
Group type: EXPERIMENTAL
Intervention: CT measurements of AAA diameter (local and central)
Number of subjects: 806
Study 7776474 — intervention group
Group type: EXPERIMENTAL
Intervention: Central CT remeasurements
Number of subjects: 806
Study 7776474 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound measurements compared to central CT measurements
Number of subjects: 806
Study 2262582 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan containing oral hygiene products
Number of subjects: 16
Study 2262582 — intervention group
Group type: EXPERIMENTAL
Intervention: Stannous fluoride containing oral hygiene products
Number of subjects: 16
Study 2262582 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine rinse
Number of subjects: 16
Study 2262582 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study 441879 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron therapy
Number of subjects: 55
Study 441879 — intervention group
Group type: COMPARATOR
Intervention: Oral iron therapy
Number of subjects: 55
Study 31192643 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents who received additional guidance to focus on teaching numbers during tablet play.
Number of subjects: 51
Study 31192643 — intervention group
Group type: COMPARATOR
Intervention: Parents who did not receive additional guidance to focus on teaching numbers during tablet play.
Number of subjects: 51
Study 28476871 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9340
Study 28476871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340
Study 26367529 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet (2.4 g protein/kg/d)
Number of subjects: 40
Study 26367529 — intervention group
Group type: COMPARATOR
Intervention: Low protein diet (0.4 g protein/kg/d)
Number of subjects: 40
Study 23615479 — intervention group
Group type: EXPERIMENTAL
Intervention: IV + OR
Number of subjects: 12
Study 23615479 — intervention group
Group type: EXPERIMENTAL
Intervention: IV and IV + OR
Number of subjects: 12
Study 23615479 — intervention group
Group type: EXPERIMENTAL
Intervention: IV + OR [AVP]
Number of subjects: 12
Study 22518934 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C treatment group (1000 mg d(‐1))
Number of subjects: 30
Study 22518934 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 30